Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-31 Sale | 2023-06-02 5:00 pm | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 125,000 | $34.11 | $4,263,915 | 3,500,000 (Direct) | View |
| 2023-05-12 Sale | 2023-05-17 07:13 am | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 25,000 | $33.84 | $846,000 | 3,625,000 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 5:19 pm | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 250,000 | $34.3 | $8,575,030 | 3,650,000 (Direct) | View |
| 2023-04-20 Sale | 2023-04-26 08:36 am | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 200,000 | $29.12 | $5,823,760 | 3,900,000 (Direct) | View |
| 2023-03-31 Sale(A) | 2023-04-06 7:31 pm | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 200,000 | $31.25 | $6,250,000 | 4,100,000 (Direct) | View |
| 2023-03-31 Sale | 2023-04-06 6:43 pm | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 200,000 | $31.25 | $6,250,000 | 4,100,000 (Direct) | View |
| 2022-08-16 Purchase | 2022-08-19 06:56 am | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 30,684 | $13.87 | $425,648 | 4,300,000 (Direct) | View |
| 2022-07-21 Sale | 2022-07-25 7:16 pm | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 34,658 | $11.21 | $388,516 | 4,330,684 (Direct) | View |
| 2022-06-24 Sale | 2022-06-28 07:51 am | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 34,658 | $11.76 | $407,578 | 4,365,342 (Direct) | View |
| 2021-09-17 Purchase | 2021-09-21 4:05 pm | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 34,658 | $10.96 | $379,852 | 4,400,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2021-04-26 4:10 pm | N/A N/A | Biomea Fusion Inc. | BMEA | A2A Pharmaceuticals Inc. 10% Owner | 0 | $0 | 4,365,342 (Direct) | View |